Guanglei Nan
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Advances in Quinazolinone-Based Tumor-Targeted Inhibitors.
Journal: Chemistry & biodiversity
Published: January 19, 2026
Regulating polysaccharide structure and bioactivity via free radical degradation: a review of mechanisms, effects, and application prospects.
Journal: Frontiers in nutrition
Published: October 15, 2025
Multi-Target Therapeutic Potential of Arctii Fructus Lignans in Diabetes Mellitus and Its Complications: A Mechanistic Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 09, 2025
Mechanism-driven multitarget therapeutics for diabetic peripheral neuropathy.
Journal: Neuroscience
Published: July 15, 2025
Structural characterization of an active polysaccharide from Gardenia jasminoide and its anti-pulmonary fibrosis effect associated with TGF-β1/Smad3 signaling pathway.
Journal: International journal of biological macromolecules
Published: June 11, 2025
Non-peptidic immunoproteasome β5i-selective inhibitor as potential treatment for idiopathic pulmonary fibrosis: Virtual screening, hit evolution and lead identification.
Journal: European journal of medicinal chemistry
Published: June 14, 2023
Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors.
Journal: European journal of medicinal chemistry
Published: November 30, 2021
Novel benzamido derivatives as PTP1B inhibitors with anti-hyperglycemic and lipid-lowering efficacy.
Novel benzamido derivatives as PTP1B inhibitors with anti-hyperglycemic and lipid-lowering efficacy.
Journal: Acta pharmaceutica Sinica. B
Published: February 13, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026